Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion type Assertion NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_head.
- NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion description "[In addition, geldanamycin (HSP90 inhibitor) and two CHK1 inhibitors (UCN-01 and SB218078) exhibited a significantly stronger synergism with cisplatin in FA-proficient cells when compared to FA-deficient cells, suggesting a contribution of their FA pathway inhibitory activity to cisplatin sensitization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_provenance.
- NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion evidence source_evidence_literature NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_provenance.
- NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion SIO_000772 22537224 NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_provenance.
- NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion wasDerivedFrom befree-20150227 NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_provenance.
- NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_assertion wasGeneratedBy ECO_0000203 NP469043.RAuxXYoBUvaIzU9aWqF7f12R6URLOgSgNYH-2dR4it8t0130_provenance.